Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

K-Fast Holding AB: Interim report January–December 2020

Financial ratios for the period 1 January–31 December 2020 +---------------------------------+---------+--------+---------+---------+|  Financial ratios |    2020 |   2019 |   2020 |   2019 || | Oct–Dec |Oct–Dec | Jan–Dec | Jan–Dec |+---------------------------------+---------+--------+---------+---------+|  Rental income, SEK million |  56.2 | 44.7 | 203.9 |  156.8 |+---------------------------------+---------+--------+---------+---------+|  Profit from property |  19.1 | 8.6 | 75.3 |  52.9 |

Tecnotree Corporation Financial Report for Q4 and Full Year 2020 (unaudited)

Tecnotree Corporation Financial Statement Release 26 February 2021 at 09:00 (CET +1)Strong earnings and cash flow Fourth quarter 2020 · Fourth quarter net sales was EUR 14.2 (14.1) million. · The adjusted operating result for the quarter was EUR 4.3 (4.1) million and the operating result 4.3 (4.1) million. · The adjusted result for the quarter was EUR 4.3 (2.8) million and the result EUR 4.3 (2.8) million · The order book at the end of the period stood at EUR 32.1 (25.5) million. · Fourth quarter cash flow after investments was EUR 2.3 (-1.3) million. · Earnings per

Year-end report 2020

Gothenburg, February 26, 2021 - Vicore Pharma Holding AB (publ) publishes the year-end report for 2020.Important events during the fourth quarter · In October, Vicore announced completion of patient enrollment in the phase II study in patients with COVID-19. · In October, Vicore announced the nomination committee for the 2021 Annual General Meeting. · In November, Vicore strengthened its pipeline with the acquisition of novel AT2R (angiotensin II type 2-receptor) agonists and decided on an issue in kind of 142,054 shares. · In November, Vicore announced changes in the

Saga Pure ASA: Prospectus Summary for transfer of listing from Euronext Expand to Oslo Børs

Oslo, Norway, 26 February 2021. Reference is made to the announcement on 24 February 2021 regarding Oslo Børs' resolution to admit the shares of Saga Pura ASA to listing on Oslo Børs. The first day of trading of the Company's shares on Oslo Børs will be on 1 March 2021. Consequently, the last day of trading of the Company's shares on Euronext Expand will be today, 26 February 2021. The ticker and ISIN of the Company's shares will remain unchanged. In connection with the transfer of listing from Euronext Expand to Oslo Børs, Saga Pure ASA hereby publish a prospectus summary, serving

Scout Gaming publishes Q4 2020: Revenues increased 69% to SEKm 16.9, EBITDA improved to SEKm -5.8, positive cashflow from operating activities

“We continue to undergo strong growth, revenues increased by 69% to SEK 16.9 million during the fourth quarter and during the full year 2020, total revenue base amounted to SEK 46.9 million. During the full year, total revenue base thus grew by 84 percent, despite a strong negative impact from COVID-19 at the end of the first and sizable parts of the second quarter - when the global sports calendar was halted. In a longer perspective, COVID-19 has resulted in a faster pace of digitalization in general and for companies operating in the entertainment sector in particular, which has benefited

Frill Holding AB publishes financial report 2020

STOCKHOLM, February 26, 2021 08:00 CET This information is information that Frill Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation.In December 2020, Frill Holding completed the acquisition of Bezzt AB and initiated a strategy that will strengthen the company and the brands associated with it. The acquisition is reported in accordance with the principles for reverse acquisition, where Bezzt is seen as the accounting acquirer and Frill Holding as the acquired party. Following the acquisition, the shareholders in Bezzt AB own 53% of the shares in Frill Holding

Swedbank Robur Sustainable Investments 2020

Swedbank Robur's annual report Sustainable Investments presents how the fund company integrate, support and push sustainability issues through their investments. At the beginning of 2020, Swedbank Robur started the implementation of their climate strategy, and launched six funds defined to be managed in line with the Paris Agreement. Swedbank Robur Råvarufond was also transformed into Transition Energy - and got a new and changed investment focus to encompass companies that contribute to the energy supply of the future. In addition, the fund company’s Policy for Responsible Investments was

ZINZINO AB (PUBL): YEAR-END REPORT 2020

INCREASED SHARE DIVIDEND AFTER RECORD CLOSING OF THE YEAR The fourth quarter of 2020 was the strongest quarter ever in the Company’s history regarding sales. Total revenues in the Group increased by 44% and amounted to SEK 340.4 (236.3) million. This is due to sales growth in all regions. The strongest growth continued to be found in the Central European countries, but Asia and North America also increased significantly during the quarter. Profitability was also very good and the EBITDA result amounted to SEK 37.4 (6.3) million for the quarter. The EBITDA margin amounted to the record

Mycronic receives order for two SLX systems

Mycronic AB (publ) has received an order for two SLX mask writers from an existing customer in the USA. The total order value is between USD 8 and 12 million. Delivery of the first SLX system is scheduled for the fourth quarter of 2021, while delivery of the second system is scheduled for the first half-year of 2022.The SLX laser mask writer was launched in October 2019 to meet rising demand for photomasks for the semiconductor industry, which is driven by long-term trends, and to meet the future need for replacement and modernization. Photomasks made by laser mask writers are very

DanCann Pharma A/S publishes Year-end report for 2020

COPENHAGEN, Denmark, 26 February 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) today releases its results for the period 1 January – 31 December 2020. The Year-end report is available as an attached document to this press release and on www.dancann.com.Fourth quarter 2021 (1 October – 31 December) · Net sales was KDKK 0 (0) · Operating profit (EBIT) was -2,721 (-493) · Result per share (DKK) was -0.07 (-460,000)* · Equity ratio was 0.89 (-0.42) Full year 2020 (1 January – 31 December) · Net sales was KDKK 0 (0) · Operating profit (EBIT)

Recurring revenue continues to grow while churn remains at 0%

Interim Report October 1st – December 31th, 2020   • Despite a quarter with lead times affected by the pandemic, the Annual Recurring Revenue(ARR) increased with +37% year-on-year, to 23,8 MSEK.• The transformation in 2020 came to full completion in the fourth quarter. On a full-year basisrecurring revenues accounted for 90% of total revenues.• Churn in Q4 remains at 0%.• On January 25th, Safeture carried out a directed share issue of 4,6 million shares worth 38,6MSEK in new cash.Summary of Interim Report The Group Full Year (2020-01-01 to 2020-12-31) · Net

Year-end Report January-December 2020

SECURED FINANCING OF KARLATORNETOctober–December 2020 · Order bookings amounted to SEK 4,852 million (2,969). · Income amounted to SEK 2,166 million (2,253). · Operating loss amounted to SEK 47 million (97). · Cash flow from operating activities amounted to SEK 204 million (83). · Loss for the period amounted to SEK 72 million (63). · On December 17, 2020, Serneke and Balder entered a share transfer agreement meaning that Balder acquires 50 percent of the shares of Karlatornet AB (“the Joint Venture”). The Joint Venture is a newly established company that has acquired

Number of shares and votes in Medivir

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the number of shares and votes in Medivir has changed during February 2021 as a result of the previously announced rights issue and over-allotment option and which in total resulted in an increase of 27,847,833 class B shares. Today, the last trading day of the month, there are in total 52,135,651 shares in Medivir, of which all are class B shares with in total 52,135,651 corresponding voting rights. For additional information, please contactYilmaz Mahshid, CEOTelephone: +46 8 5468 3100E-mail: yilmaz.

myFC Holding AB (publ) year-end report January – December 2020

Full year January – December 2020· Net sales amounted to KSEK 0 (0) · Operating loss amounted to SEK -48 million (-165) · Earnings per share amounted to SEK -0.31 (-1.76) Quarter October – December 2020 · Net sales amounted to KSEK 0 (0) · Operating loss amounted to SEK -12 million (-17). · Earnings per share amounted to SEK -0.08 (-0.15) Significant events October – December · Directed share issues in myFC bring in SEK 36 million and a Share Subscription Agreement signed with Global Emerging Markets adds an additional SEK 150 million of available funding ·

Interim report October - December 2020

Quant releases the interim report for October - December 2020.October-December · Net sales for the period decreased by 13.7% to EUR 43.4 (50.3) million. Organically, net sales decreased by 7.3% · During the quarter, the contract portfolio decreased as nine contracts were lost, two contracts were won, and one contract was renewed. Portfolio run rate annualized net sales at the end of the quarter was EUR 140.5 million, compared to EUR 165.4 million during the third quarter of 2020 · Operating loss amounted to EUR -1.3 million, compared to a profit of EUR 0.8 million prior year ·

Nordic Iron Ore AB secures financing of SEK 20.9 million

Nordic Iron Ore AB ("Nordic Iron Ore" or "the Company") has decided to raise loans totaling SEK 20.9 million. The motive is to provide working capital to evaluate alternative financing options and continued design work.As previously announced, Nordic Iron Ore received a very positive result in November 2020 from the optimization study for the project in Blötberget. Based on this study, discussions have been initiated regarding the project's long-term financing. - The iron ore market is very strong, not least in terms of demand for the high-quality product that we will produce. These are

XNK Therapeutics partners with Karolinska Institutet on Phase II study in patients with multiple myeloma with support from Sanofi

XNK Therapeutics AB (“XNK”) today announced that it is entering into a joint Phase II clinical study to treat patients with multiple myeloma using XNK’s leading drug candidate in combination with Sanofi’s anti-CD38 antibody Sarclisa (isatuximab). XNK and Sanofi are both collaborative partners within NextGenNK Competence Center coordinated by Karolinska Institutet.The investigator-initiated Phase II study is made possible by the three parties’ contributions to the trial. XNK will provide its novel autologous NK cell-based product to the study set to take place at the Karolinska University

Kamux Corporation’s Financial Statements Bulletin for January 1 - December 31, 2020

Kamux Corporation Financial Statements Bulletin February 26, 2021 at 09:00 Kamux Corporation’s Financial Statements Bulletin for January 1 - December 31, 2020 Kamux Saw Strong and Very Profitable Growth - Revenue Growth +13.3% and Adjusted Operating Profit +38.8% The figures in parentheses refer to the comparison period, i.e. the same period in the previous year, unless stated otherwise. October-December in brief- Revenue increased by 13.3%, totaling EUR 198.8 million (175.4) - Gross profit increased by 18.7% to EUR 23.8 million (20.0), or 12.0% (11.4) of revenue -

ICA Gruppen publishes annual report 2020

ICA Gruppen’s annual report for 2020 is now available at www.icagruppen.seThe annual report, which also includes ICA Gruppen’s sustainability report, is available as a downloadable PDF document. To read or download the annual report in English, go to: www.icagruppen.se/en/annual-report-2020 To read or download the annual report in Swedish, go to: www.icagruppen.se/arsredovisning-2020 For environmental and cost reasons, and because ICA Gruppen is increasingly switching to digital communication, from the 2018 Annual Report onwards ICA Gruppen has decided to no longer provide a

Otello trading update

AdColony update AdColony continued the strong growth in 4Q20 delivering revenue growth of 34% vs 4Q19. This is substantially above guidance of 10-15% revenue growth provided at our 3Q20 presentation and above the 30% updated guidance we provided in our profit warning on 21. December 2020. 4Q20 Our Brand business continues to outgrow the market and posted 43% YoY growth in 4Q20 vs 4Q19, driven in particular by our Programmatic business. In addition, our Performance business delivered in 4Q20 the first quarter with quarter with YoY growth since 2016. Despite the strong revenue growth,

Notice to the annual general meeting of UPM-Kymmene Corporation

UPM-Kymmene Corporation       Stock Exchange Release (Notice to General Meeting)     26 February 2021 at 09:00 EET Notice to the annual general meeting of UPM-Kymmene Corporation Notice is given to the shareholders of UPM-Kymmene Corporation of the Annual General Meeting to be held on Tuesday, 30 March 2021 starting at 14.00 (EEST) in UPM-Kymmene Corporation’s headquarters at Biofore House, Alvar Aallon katu 1, Helsinki, Finland. The Company’s shareholders can participate and exercise their shareholder rights in the Annual General Meeting only by voting in advance and by submitting

Kamux Corporation’s Share-Based Long-Term Incentive Plan for 2021―2023

Kamux Corporation    Stock Exchange Release    26 February 2021 at 8:50 (EET) Kamux Corporation’s Share-Based Long-Term Incentive Plan for 2021―2023 The Board of Directors of Kamux Corporation have decided to approve the new long-term incentive plan for the Group’s key persons for 2021-2023 (the “Plan”). The aim of the Plan is to encourage and strengthen the commitment of the Group's key persons to implement a long-term strategy and increase shareholder return, as well as to align the objectives of the company's shareholders and key persons in order to increase the company's value.

There are no items matching the current filter
There are no more items matching the current filter
Back to top